Related Experiment Video
Updated: Aug 11, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
Protein kinase CK2 subunits are positive regulators of AKT kinase
1Institute for Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230 Odense, Denmark. bag@bmb.sdu.dk
Abstract:
Protein kinase CK2 is a highly conserved serine/threonine kinase ubiquitously distributed in all investigated eukaryotes and involved in several intracellular pathways which control, among others, cell cycle, proliferation, apoptosis and transformation. Similarly, the PI3K-AKT pathway deregulation has been shown to play an important role in tumor development and tumor response to anti-cancer treatment. In this study, it is shown that the specific inhibition of the PI3K-AKT signaling pathway in combination with depletion of CK2 subunits by antisense oligodeoxynucleotides leads to an enhanced drug-induced apoptotic response. Moreover, in vitro as well as in vivo studies show that the individual CK2 subunits interact with AKT kinase and that the complex formation is not modulated by the phosphorylation status of AKT. Furthermore, the fact that the interaction between CK2 subunits and AKT enhances AKT kinase activity identifies a novel molecular mechanism that leads to modulation of AKT activation raising the possibility that CK2 and AKT might be implicated in common pathways that control cell proliferation and survival.
Insights
Combining PI3K-AKT pathway inhibition with CK2 subunit depletion enhances cancer drug response. CK2 subunits interact with AKT, boosting its activity, suggesting a role in cell proliferation and survival pathways.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Protein kinase CK2 is a conserved kinase regulating cell cycle, proliferation, apoptosis, and transformation.
- Deregulation of the PI3K-AKT pathway is crucial in tumor development and response to anti-cancer therapies.
Purpose of the Study:
- To investigate the combined effect of PI3K-AKT pathway inhibition and CK2 subunit depletion on drug-induced apoptosis.
- To elucidate the interaction between CK2 subunits and AKT kinase and its functional consequences.
Main Methods:
- Antisense oligodeoxynucleotides for CK2 subunit depletion.
- Specific inhibition of the PI3K-AKT signaling pathway.
- In vitro and in vivo studies to assess drug-induced apoptosis and protein interactions.
Main Results:
- Combined inhibition of PI3K-AKT and CK2 depletion significantly enhanced drug-induced apoptosis.
- CK2 subunits were found to interact with AKT kinase.
- This interaction enhances AKT kinase activity, independent of AKT phosphorylation status.
Conclusions:
- CK2 and AKT kinase may be involved in common pathways regulating cell proliferation and survival.
- The interaction between CK2 and AKT represents a novel mechanism for modulating AKT activation.
- Targeting both CK2 and the PI3K-AKT pathway could be a promising strategy for cancer treatment.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Positive Regulator Molecules
Positive Regulator Molecules
cAMP-dependent Protein Kinase Pathways
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

